Pixantrone BBR

Related by string. * pixantrone : anthracyclines pixantrone inhibits Topo . DNA pixantrone alkylates . OPAXIO pixantrone . pixantrone NDA . Pixantrone / : BBR Staff Writer . BBR . TSX VENTURE BBR * *

Related by context. Frequent words. (Click for all words.) 59 polymerase inhibitors 59 EZN 58 multi kinase inhibitor 58 CYC# 58 induces apoptosis 57 humanized anti 57 PEGylated 57 Small Molecule 57 Inc. Nasdaq IMGN 57 phosphoinositide 3 57 Voreloxin 57 Tesetaxel 57 novel orally administered 57 Pharmion Corporation 56 HCV protease 55 hypoxia inducible factor 55 Idera Pharmaceuticals 55 MEK inhibitor 55 FGFR 55 Panzem R 55 Antisense 54 selective inhibitor 54 Vascular Endothelial Growth 54 Genaera Corporation 54 Oncogene 54 drug conjugate 54 Chemokine 54 oncolytic 53 sphingosine 1 53 Guanilib 53 OXi# 53 EnVivo Pharmaceuticals 53 Neurogen Corporation 53 anti proliferative 53 humanized monoclonal antibody 53 Epratuzumab 53 HCV protease inhibitor 52 liposomal formulation 52 small molecule inhibitor 52 synthetic peptide 52 immunomodulatory 52 small molecule inhibitors 52 tyrosine kinase inhibitor 52 Celator 52 angiogenesis inhibitor 52 anticancer compound 52 humanized antibody 52 VQD 51 #ME# 51 anticancer agent 51 Cetrorelix 51 Debio 51 FLT3 51 Zolinza 51 prodrugs 51 PEG SN# 51 anti fibrotic 51 nicotinic alpha 7 51 P#X# 51 Wnt signaling pathway 51 Monoclonal Antibody 51 Molecular Cancer 51 Versartis 51 dependent cellular cytotoxicity 51 Sym# 51 selectively inhibit 50 IMC A# 50 Chemokine Therapeutics 50 cancer immunotherapies 50 Drug Candidate 50 JAK3 50 proteasome inhibitors 50 sodium Injection 50 deforolimus 50 anticancer compounds 50 investigational compounds 50 Angiogenesis 50 PARP inhibitor 50 mTOR inhibitor 50 CTCE 50 Aliskiren 50 PXD# 50 #:#-# [023] 50 Neurologix Inc. 50 atacicept 50 GSK # 50 xenograft models 49 antiviral compounds 49 SGLT2 49 GPR# [002] 49 R bortezomib 49 short interfering RNA 49 Dasatinib 49 Atiprimod 49 antiangiogenic 49 Irinotecan 49 small molecule 49 immunotherapeutic 49 SERMs 49 B Raf 49 Gastrointestinal Cancers Symposium

Back to home page